At Royds Withy King we are still able to serve all your legal needs during the Coronavirus pandemic. Find out more.

Search our news, events & opinions

9 September 2020 0 Comments
Posted in Brexit, Opinion

End of Brexit transition period – what now for medicines and medical devices?

Author headshot image Posted by , Partner

With the end of the Brexit transition period fast approaching it is becoming more and more urgent for businesses in the medical sector to prepare for the transition period coming to an end. It is a sector, where many of the rules stem from EU regulation, which makes it even more important for businesses to prepare.

To this end the Medicines and Healthcare products Regulatory Agency (MHRA) has produced a set of guidance notes, which explain the rules in relation to:

  1. Clinical Trials
  2. Devices
  3. Licensing
  4. Importing and exporting
  5. IT systems
  6. Pharmacovigilance and
  7. Paediatrics

The rules are quite complex and businesses this sector should consider how the end of the transition period may affect them and plan for the effects. The guidance can be found here.

 

If you have any questions about how Brexit may impact your business, please feel free to contact Claus Andersen on:`

020 7842 1462     Email usclaus.andersen@roydswithyking.com

Leave a comment

Thank you for choosing to leave a comment. Please keep in mind that comments are moderated and please do not use a spammy keyword or a domain as your name or it will be deleted.

*required*

**required*

*optional*

Brexit

From your business through to your personal life, we bring clarity to the Brexit negotiations.

Learn more

Partner

T: 020 7842 1462 (DDI)
Email

Search our news, events & opinions